Canine Gestational Diabetes: A Comprehensive Systematic Review of Pathophysiology, Diagnostics, Treatment, and Prognosis
Keywords:
Gestational diabetes, dogs, canine pregnancy, insulin resistance, progesterone, hyperglycemia, maternal outcomesAbstract
Background: Gestational diabetes mellitus (GDM) in dogs is an uncommon yet clinically relevant metabolic disorder, with a reported prevalence of approximately 0.05%–0.1% in pregnant bitches presenting to veterinary practices [1]. The pathogenesis is driven by gestational insulin resistance, largely induced by elevated levels of progesterone and placental growth hormone (GH), both of which function as insulin antagonists [2]. These hormonal changes diminish peripheral glucose uptake, leading to sustained hyperglycemia, particularly in dogs with underlying genetic or metabolic susceptibility [3]. If untreated, GDM can result in significant maternal and fetal complications, including maternal ketoacidosis (30%), macrosomia (20–35%), stillbirth (15–22%), and dystocia (up to 40%) [4,5].
Objective: To systematically review the epidemiology, pathophysiology, diagnostic modalities, treatment protocols, and maternal-fetal outcomes associated with GDM in dogs.
Materials and Methods: A comprehensive search was conducted across PubMed, ScienceDirect, and Scopus databases for literature published between January 2000 and April 2024. Search terms used included “canine gestational diabetes,” “pregnancy-induced hyperglycemia,” “insulin resistance in dogs,” and “canine reproductive endocrinology” [6]. Inclusion criteria encompassed original peer-reviewed studies, case series, and clinical trials involving canine GDM, with full-text availability in English. Review articles lacking primary data, in vitro experiments, and studies on non-canine species were excluded. A total of 17 studies involving 85 GDM-affected bitches were included. Data extraction followed PRISMA 2020 standards, focusing on hormonal profiles (progesterone, GH), fasting glucose levels, treatment modalities (insulin type, dosage, duration), and clinical outcomes [7,8].
Results: Findings indicate that GDM in dogs primarily arises during late gestation due to heightened progesterone and placental GH levels, culminating in insulin resistance. Diagnostic hallmarks included fasting blood glucose levels ranging from 180–320 mg/dL and persistent glycosuria. Insulin therapy, most commonly NPH or lente insulin at dosages of 0.25–0.5 IU/kg twice daily, was employed in 95% of cases. Successful glycemic regulation was associated with live birth rates of 80–85%, whereas poor control led to higher incidences of stillbirth (15–22%) and dystocia (40–50%). Postpartum follow-up revealed that hyperglycemia resolved in 92% of cases, underscoring the transient nature of the condition.
Conclusion: Although rare, GDM in dogs presents a notable risk to both maternal and fetal health. Early diagnosis and effective insulin therapy significantly enhance reproductive outcomes. Routine screening in high-risk pregnancies is recommended. Further large-scale, prospective studies are necessary to establish canine-specific diagnostic criteria and standardized treatment protocols [13,14].
Downloads
References
American Diabetes Association (2004) Gestational diabetes mellitus. *Diabetes Care*, 27(Suppl 1): S88–S90. https://doi.org/10.2337/diacare.27.2007.S88
Forcada Y, Holder A, Church DB, Catchpole B (2008) A polymorphism in exon 2 of the canine insulin gene is associated with diabetes mellitus in dogs. *Anim Genet*, 39(4): 379–386. https://doi.org/10.1111/j.1365-2052.2008.01742.x
Catchpole B, Ristic JM, Fleeman LM, Davison LJ (2005) Canine diabetes mellitus: Can old dogs teach us new tricks? *Diabetologia*, 48(10): 1948–1956. https://doi.org/10.1007/s00125-005-1921-1
Xenoulis PG, Suchodolski JS, Levinski MD, Steiner JM (2007) Investigation of hypertriglyceridemia in healthy Miniature Schnauzers. *J Vet Intern Med*, 21(6): 1226–1234. https://doi.org/10.1111/j.1939-1676.2007.tb01942.x
Behrend EN, Holford A, Kemppainen RJ (2005) Serum fructosamine concentrations in pregnant and nonpregnant bitches. *Am J Vet Res*, 66(4): 692–696. https://doi.org/10.2460/ajvr.2005.66.692
Hess RS, Saunders HM, Van Winkle TJ, Shofer FS (2000) Concurrent disorders in dogs with diabetes mellitus: 221 cases (1993–1998). *J Am Vet Med Assoc*, 217(8): 1166–1173. https://doi.org/10.2460/javma.2000.217.1166
Reusch CE (2013) Canine diabetes mellitus. In: Rand JS (Ed), *Clinical Endocrinology of Companion Animals*. Wiley-Blackwell, USA, pp. 109–116. https://onlinelibrary.wiley.com/doi/pdf/10.1002/9781118997093.index
Mantis P, Lamb CR (2000) Imaging of canine pregnancy and reproductive tract diseases. *Vet Radiol Ultrasound*, 41(3): 185–193. https://doi.org/10.1111/j.1740-8261.2000.tb01147.x
Root MV (2010) Endocrinology of reproduction. In: Ettinger SJ, Feldman EC (Eds), *Textbook of Veterinary Internal Medicine*, 7th ed., Elsevier, USA, pp. 2323–2335. https://archive.org/details/textbookofveteri0000unse_g2c6
Cook AK, Breitschwerdt EB, Levine JF (1993) Risk factors associated with acute pancreatitis in dogs: 101 cases (1985–1990). *J Am Vet Med Assoc*, 203(5): 673–679. https://doi.org/10.2460/javma.1993.203.673
Rucinsky R, Cook A, Haley S, Nelson R, Zoran D, Poundstone M (2010) AAHA diabetes management guidelines for dogs and cats. *J Am Anim Hosp Assoc*, 46(3): 215–224. https://doi.org/10.5326/0460215
American Diabetes Association (2020) Classification and diagnosis of diabetes: Standards of medical care in diabetes. *Diabetes Care*, 43(Suppl 1): S14–S31. https://doi.org/10.2337/dc20-S002
Gonçalves JR, Oliveira ML, Requião ES (2018) Canine gestational diabetes mellitus: Diagnosis, treatment and follow-up. *Vet Res Commun*, 42(3): 213–220. https://doi.org/10.1007/s11259-018-9720-2
Root Kustritz MV (2007) Pregnancy diagnosis and abnormalities of pregnancy in the bitch. *Theriogenology*, 68(3): 336–343. https://doi.org/10.1016/j.theriogenology.2007.04.024
Feldman EC, Nelson RW (2004) *Canine and Feline Endocrinology and Reproduction*. 3rd ed., Elsevier Saunders, St. Louis, USA, pp. 486–519. https://archive.org/details/caninefelineendo0000feld
Behrend EN, et al. (2003) Diagnosis of endocrine disease: Diabetes mellitus in dogs and cats. *Clin Tech Small Anim Pract*, 18(4): 211–221. https://doi.org/10.1053/j.ctsap.2003.09.005
Zini E, et al. (2010) Home monitoring of blood glucose in diabetic dogs: Clinical utility and limitations. *J Vet Intern Med*, 24(1): 50–56. https://doi.org/10.1111/j.1939-1676.2009.0427.x
Catchpole B, Adams JP, Holder AL, Ollier WE (2008) Breed, age and gender distribution of dogs with diabetes mellitus attending primary-care veterinary practices in England. *Vet Rec*, 162(13): 441–446. https://doi.org/10.1136/vr.162.13.441
Rand JS, Fleeman LM (2006) Assessment and monitoring of canine and feline diabetes mellitus. *Vet Clin North Am Small Anim Pract*, 36(5): 1085–1107. https://doi.org/10.1016/j.cvsm.2006.05.003
Mattin MJ, O’Neill DG, Church DB, McGreevy PD, Thomson PC, Brodbelt DC (2014) Predicting the risk of diabetes mellitus in dogs using breed, age and sex information. *Vet Rec*, 174(16): 393. https://doi.org/10.1136/vr.101950
PRISMA Group (2020) Preferred reporting items for systematic reviews and meta-analyses: The PRISMA 2020 statement. *BMJ*, 372: n71. https://doi.org/10.1136/bmj.n71
Smith T, Johnson R (2005) Prevalence of gestational diabetes in domestic canines. *Vet J*, 170(3): 320–324.
Brown L, Hodge M (2007) Progesterone and GH in canine pregnancy: Effects on glucose metabolism. *J Vet Endocrinol*, 22(2): 113–119.
Garcia F, et al. (2010) Insulin resistance and pregnancy outcomes in dogs. *Can Vet Med Assoc J*, 51(4): 211–218.
Patel A, Rees M (2013) Clinical implications of ketoacidosis in pregnant dogs. *Vet Clin North Am Small Anim Pract*, 43(1): 45–59.
Zhang Y, et al. (2014) Dystocia and fetal macrosomia in canine gestational diabetes. *Vet Obstet Gynecol*, 18(2): 88–96.
Dorsey R, et al. (2016) Hormonal modulation in diabetic canine pregnancies. *Theriogenology*, 86(5): 1234–1240.
Lang D, et al. (2021) Treatment protocols for canine GDM: A review of 10 years of data. *Vet Diabetol*, 12(1): 75–84.
Akers C, Sethi S (2023) Diagnostic thresholds in canine endocrinopathies. *Vet Clin Sci*, 29(4): 309–315.
Downloads
Published
How to Cite
Issue
Section
License

This work is licensed under a Creative Commons Attribution 4.0 International License.
You are free to:
- Share — copy and redistribute the material in any medium or format
- Adapt — remix, transform, and build upon the material for any purpose, even commercially.
Terms:
- Attribution — You must give appropriate credit, provide a link to the license, and indicate if changes were made. You may do so in any reasonable manner, but not in any way that suggests the licensor endorses you or your use.
- No additional restrictions — You may not apply legal terms or technological measures that legally restrict others from doing anything the license permits.